Advertisement
News
Subscribe to MDT Magazine News

Heparin Sodium (B. Braun): Recall - Trace Contaminant

October 29, 2010 1:31 pm | by U.S. Food & Drug Administration | Comments

Oversulfated chondroitin sulfate (OSCS) contaminant found during sample testing.

TOPICS:

Roche Introduces Immunoassay Module for cobas® 8000 Modular Analyzer Series In U.S.

October 29, 2010 10:31 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, Oct. 29 /- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas® 8000 modular analyzer series for diagnostic labs with high-volume workloads. Labs will now be able to combine this new...

TOPICS:

Methotrexate Injection, 50mg/2mL and 250mg/10mL Vials: Recall - Presence of Glass Particulates

October 29, 2010 9:35 am | by U.S. Food & Drug Administration | Comments

Potential to develop adverse reactions in areas where the particles lodge, which could result in serious adverse events, disability, or death.

Advertisement

ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences

October 29, 2010 9:34 am | by Bio-Medicine.Org | Comments

EXTON, Pa., Oct. 29 /- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that William Roberts, vice president, corporate communications of ViroPharma, will present at the Oppenheimer 21st Annual Healthcare Conference at 3:55 P.M. ET on Tuesday, November 2, 2010.  The conference...

TOPICS:

Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R & D Alliance

October 29, 2010 9:34 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Oct. 29 /- Covance Inc (NYSE: CVD ) today announced that it has closed its transactions with sanofi-aventis to become its R&D partner over the next 10 years and to purchase sanofi-aventis' Porcheville, France and Alnwick, United Kingdom sites.  Covance has...

TOPICS:

Neighborhood House, Health Center Team Up

October 29, 2010 9:33 am | by San Diego Business Journal | Comments

Two San Diego community organizations are joining forces to enhance health care assistance to 8,000 San Diego County preschool children.

TOPICS:

Lilly CEO: 'Are We Getting Our Money's Worth from Medical Innovation?'

October 29, 2010 9:33 am | by Bio-Medicine.Org | Comments

DALLAS, Oct. 29 /- In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company (NYSE: LLY ), said that the value of medical innovation – particularly innovative medicines – far outstrips its cost....

TOPICS:

VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer

October 29, 2010 9:32 am | by Bio-Medicine.Org | Comments

NEW YORK, Oct. 29 /- See video from Roche Pharmaceuticals at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=23a45dd7-b318-43fa-8347-3c5321bad198&alertid=71250c6c-8d9b-4962-8576-f46b2ca2916d&bhcp=1 Roche announced on October 29 that the European Commission has...

TOPICS:
Advertisement

New report underlines the threat to universal access to HIV prevention, treatment and care due to a slow-down in treatment scale-up and waning political will

October 29, 2010 8:35 am | by EurekAlert | Comments

(International AIDS Society) A report issued today by the International AIDS Society, Universal Access: Right Here, Right Now documents the principal debates around universal access during the XVIII International AIDS Conference (AIDS 2010). The report also takes stock of progress...

TOPICS:

Henry Schein 3Q profit falls on costs

October 29, 2010 7:45 am | by The Associated Press | Comments

Medical device and services distributor Henry Schein Inc. said Thursday its third-quarter profit fell 9 percent on higher costs and a boost in tax expenses.The company reported net income of $87.9 million, or 94 cents per share, for the three months ended Sept. 25, down from $96.4 million, or...

CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers

October 29, 2010 7:33 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif. and SPRINGFIELD, Va. Oct. 29 /- Varian Medical Systems, Inc. (NYSE: VAR ) today announced that CURE Foundation has placed an order for five Varian TrueBeam™ systems for stereotactic radiosurgery and radiation therapy.   CURE Foundation, which placed the order...

TOPICS:

Accuray Announces Expanded Service Program

October 29, 2010 7:33 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Oct. 29 /- Accuray Incorporated, a global leader in the field of radiosurgery, announced today expansion of its Diamond service program to address the unique technical, business and operational needs of its customers. The Diamond service program has provided a means for...

TOPICS:

Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting

October 29, 2010 7:32 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Oct. 29 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that 40 accepted abstracts highlighting the use of the CyberKnife Robotic Radiosurgery System will be presented as posters and presentations at the 52nd Annual...

TOPICS:

CyberKnife® VSI™ System Expands Treatment Applications and Significantly Reduces Treatment Times

October 29, 2010 7:32 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Oct. 29 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today feedback from Creekside Cancer Care on their use of the CyberKnife VSI System .  Creekside Cancer Care was the first facility in the world to install and...

TOPICS:

LifePoint Hospitals 3Q profit rises 24 percent

October 29, 2010 6:45 am | by The Associated Press | Comments

Rural hospital operator LifePoint Hospitals Inc. said Friday its third-quarter net income climbed 24 percent on a surge in revenue along with a favorable tax adjustment.The company said it earned $38.8 million, or 73 cents per share, up from $31.4 million, or 58 cents per share, in the same...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading